Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

Clinical trial NCT04846959 · RECRUITING

Trial details

NCT number: NCT04846959
Sponsor: AbbVie
Status: RECRUITING
Study type: OBSERVATIONAL

Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment

Start date: 2021-07-30
Primary completion: 2032-06-01
Enrollment: 818

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.